The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated study results of novel FAK/ALK/ROS1 inhibitor APG-2449 in patients (pts) with non-small-cell lung cancer (NSCLC) resistant to second-generation ALK inhibitors.
 
Yuxiang Ma
No Relationships to Disclose
 
Hongyun Zhao
No Relationships to Disclose
 
Jianhua Chen
No Relationships to Disclose
 
Zhengbo Song
No Relationships to Disclose
 
Yanqiu Zhao
No Relationships to Disclose
 
Yubiao Guo
No Relationships to Disclose
 
Gang Wu
No Relationships to Disclose
 
Hua Yang
No Relationships to Disclose
 
Xiaoqing Yu
No Relationships to Disclose
 
Fangfang Gao
No Relationships to Disclose
 
Ruiguang Zhang
No Relationships to Disclose
 
Jian Fang
No Relationships to Disclose
 
Xiaoyan Lin
No Relationships to Disclose
 
GuangLin Liu
Employment - Ascentage Pharma
Honoraria - Ascentage Pharma
 
Chen Yang
Employment - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Lichuang Men
Employment - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Eric Liang
Employment - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Dajun Yang
Employment - Ascentage Pharma; Ascentage Pharma
Leadership - Ascentage Pharma; Ascentage Pharma; Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Li Zhang
No Relationships to Disclose
 
Yifan Zhai
Employment - Ascentage Pharma; Ascentage Pharma
Leadership - Ascentage Pharma; Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma